Wells Fargo & Company Upgrades Voyager Therapeutics (NASDAQ:VYGR) to “Overweight”
Wells Fargo & Company upgraded shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) from an equal weight rating to an overweight rating in a research note issued to investors on Tuesday, MarketBeat reports. The firm currently has $14.00 price target on the stock, up from their previous price target of $9.00. Other research analysts also […]
More Stories
iShares 1-3 Year Treasury Bond ETF (NASDAQ:SHY) Shares Acquired Sen. John Boozman
Senator John Boozman (R-Arkansas) recently bought shares of iShares 1-3 Year Treasury Bond ETF (NASDAQ:SHY). In a filing disclosed on...
Vanguard Small-Cap Value ETF (NYSEARCA:VBR) Shares Acquired by Iron Horse Wealth Management LLC
Iron Horse Wealth Management LLC boosted its position in Vanguard Small-Cap Value ETF (NYSEARCA:VBR – Free Report) by 3.8% in...
WhiteCoin (XWC) Price Reaches $0.0163 on Top Exchanges
WhiteCoin (XWC) traded 0.7% lower against the dollar during the 1-day period ending at 12:00 PM Eastern on October 23rd....
Frontier (FRONT) Reaches Self Reported Market Capitalization of $8.85 Million
Frontier (FRONT) traded 2.5% higher against the dollar during the 24-hour period ending at 12:00 PM ET on October 23rd....
Cobak Token Hits 24-Hour Trading Volume of $1.56 Million (CBK)
Cobak Token (CBK) traded 2.9% lower against the U.S. dollar during the one day period ending at 12:00 PM ET...
cVault.finance 1-Day Volume Hits $194.67 (CORE)
cVault.finance (CORE) traded flat against the dollar during the 1-day period ending at 12:00 PM Eastern on October 23rd. One...